Elizabeth Glaser Pediatric Aids Foundation — Federal Contractor Profile
Elizabeth Glaser Pediatric AIDS Foundation Secures Significant Government Funding for HIV/AIDS Initiatives
Contractor Overview
Total Contract Value: $2,549,977,311 ($2.5B)
Total Awards: 28
Company Profile
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a prominent non-profit organization dedicated to the global eradication of pediatric HIV/AIDS. While primarily known for its extensive work in research, advocacy, and direct program implementation in affected communities, EGPAF also engages with government agencies to secure funding and support for its mission. Their core capabilities lie in public health program management, global health initiatives, HIV/AIDS prevention and treatment, and research related to infectious diseases affecting children. EGPAF's relationship with government agencies, particularly those involved in global health and international development, is crucial for their operational funding. The scale of their government business, as indicated by the provided data, appears to be concentrated in a few large awards rather than a broad portfolio of smaller contracts. This suggests a strategic focus on securing significant grants or cooperative agreements that align with their large-scale programmatic goals. The nature of their work often involves complex, long-term projects requiring specialized expertise, which may influence their contract acquisition methods. Without specific contract details, it's difficult to ascertain their win patterns (competitive vs. sole-source), but organizations of EGPAF's stature often compete for large grants through established government funding mechanisms. Their track record is largely defined by their impact on the ground in combating pediatric HIV/AIDS, with numerous successful programs and research initiatives. The contract patterns, if indeed dominated by a single large award, might indicate a strategy of seeking substantial, multi-year funding to support ambitious global health objectives, rather than a diversified approach to government contracting across various agencies or service lines.
Specializations
- Pediatric HIV/AIDS Prevention
- Global Health Program Management
- HIV/AIDS Treatment and Care
- Infectious Disease Research
- Public Health Initiatives
- International Development Support
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: N/A
Agency Concentration: high
Growth Trajectory: stable
Competitive Position
EGPAF operates in a specialized niche focused on global health, particularly pediatric HIV/AIDS. Within this specific domain, they are a recognized leader and a significant implementer of programs. Their competitive position is less about competing for general government services and more about securing large grants and cooperative agreements for their specialized mission, often against other major non-profit and international health organizations.
Value to Taxpayers
EGPAF's value to taxpayers is primarily derived from its effectiveness in leveraging government funds to achieve critical public health outcomes, specifically in combating pediatric HIV/AIDS. Given the substantial average contract size, the expectation is that these funds are directed towards large-scale, impactful programs with measurable results in disease prevention and treatment. Their specialized focus suggests that taxpayer money is being utilized by an organization with deep expertise in a complex and vital area of global health.
Agency Relationships
While specific top agency clients are not listed, EGPAF likely collaborates with agencies such as the U.S. Agency for International Development (USAID) and the U.S. Department of Health and Human Services (HHS), which are major funders of global health and HIV/AIDS initiatives. These agencies rely on EGPAF's established infrastructure and expertise to implement critical health programs in resource-limited settings.
Red Flags
- Concentrated Agency Dependence: With only one contract listed and no top agency clients identified, there's a potential for high dependence on a single funding source or agency, which can pose risks if that funding is altered or discontinued.
Green Flags
- Mission-Driven Focus: EGPAF's clear and critical mission in combating pediatric HIV/AIDS aligns with significant government public health objectives.
- Large-Scale Impact Potential: The substantial contract value suggests the capacity to undertake and manage large, impactful programs that can achieve significant public health outcomes.
Key Contracts
The provided data indicates a single government contract valued at $91,070,618 for the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). This significant award suggests that EGPAF has secured a major funding stream from the U.S. government, likely through a grant, cooperative agreement, or a large-scale contract. The absence of multiple contracts and the high average contract size point towards a strategy of focusing on substantial, long-term funding opportunities rather than a broad portfolio of smaller engagements. This type of large award is typical for organizations like EGPAF that are deeply involved in implementing complex, multi-year global health initiatives. Such contracts often require extensive programmatic expertise, robust financial management, and a proven track record of delivering results in challenging environments. The nature of this single, large contract underscores EGPAF's role as a key implementer of government-funded public health programs, particularly in areas related to HIV/AIDS prevention and treatment on a global scale. It highlights the government's reliance on specialized non-profit organizations to achieve critical foreign policy and public health objectives.
Frequently Asked Questions
What does EGPAF do for the government?
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) partners with the U.S. government to implement critical global health programs, primarily focused on the prevention of mother-to-child transmission of HIV and the provision of HIV/AIDS care and treatment for children and families. They leverage government funding to conduct research, strengthen health systems, and deliver essential health services in countries disproportionately affected by the epidemic, thereby supporting U.S. foreign policy and public health objectives.
How much taxpayer money does EGPAF receive?
Based on the provided data, EGPAF has received a total of $91.1 million through a single government contract. This represents the entirety of their listed government contract value. The average contract size is also $91,070,618, reflecting the singular nature of this award.
Is EGPAF good value for taxpayer money?
Assessing EGPAF's value requires examining their program outcomes against the significant funding received. As a leading organization in pediatric HIV/AIDS, their specialized expertise and established global presence suggest an efficient use of funds for critical public health interventions. The large contract size implies a focus on impactful, large-scale projects, and their track record in the field indicates a strong potential for delivering substantial public health benefits, making them a potentially high-value partner for taxpayer investment in global health.
How does EGPAF win its contracts?
While specific win patterns are not detailed, organizations like EGPAF typically secure government funding through competitive grant processes, cooperative agreements, and sometimes sole-source awards for specialized expertise. Their success likely hinges on demonstrating a strong programmatic track record, robust organizational capacity, alignment with agency priorities (such as global health and HIV/AIDS), and the ability to manage large, complex international projects effectively.
What agencies use EGPAF most?
The provided data does not specify EGPAF's top agency clients or list multiple contracts, making it impossible to determine which agencies rely on them most. However, given EGPAF's mission, it is highly probable that agencies such as the U.S. Agency for International Development (USAID) and potentially the U.S. Department of Health and Human Services (HHS) are significant partners, as they are primary funders of global health and HIV/AIDS initiatives.